Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
March-2018 Volume 17 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
March-2018 Volume 17 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Identifying heterogeneous subtypes of gastric cancer and subtype‑specific subpaths of microRNA‑target pathways

  • Authors:
    • Yuanhang Li
    • Weijun Bai
    • Xu Zhang
  • View Affiliations / Copyright

    Affiliations: Medical Department, Cancer Hospital of China Medical University, Shenyang, Liaoning 110042, P.R. China, Radiotherapy Department, Cancer Hospital of China Medical University, Shenyang, Liaoning 110042, P.R. China
    Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 3583-3590
    |
    Published online on: December 20, 2017
       https://doi.org/10.3892/mmr.2017.8329
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The present study aimed to classify gastric cancer (GC) into subtypes and to screen the subtype‑specific genes, their targeted microRNAs (miRNAs) and enriched pathways to explore the putative mechanism of each GC subtypes. The GSE13861 data set was downloaded from the Gene Expression Omnibus and used to screen differential expression genes (DEGs) in GC samples based on the detection of imbalanced differential signal algorithm. The specific genes in each subtype were identified with the cut‑off criterion of U>0.04, pathway enrichment analysis was performed and the subtype‑specific subpaths of miRNA‑target pathway were determined. A total of 1,263 DEGs were identified in the primary gastric adenocarcinoma (PGD) samples, which were subsequently divided into four subtypes, according to the hierarchy cluster analysis. Identification of the subpaths of each subtype indicated that the subpath related to subtype 1 was miRNA (miR)‑202/calcium voltage‑gated channel subunit α1 (CACNA1E)/type II diabetes mellitus. The nuclear factor‑κB signaling pathway was the most significantly specific pathway and subpath identified for subtype 2, which was regulated by miR‑338‑targeted suppression of C‑C motif chemokine ligand 21 (CCL21). For subtype 3, significant related pathways included ubiquitin‑mediated proteolysis and proteasome, and the important subpath was miR‑146B/proteasome 26S subunit, non‑ATPase 3 (PSMD3)/proteasome; focal adhesion was the significant pathway indicated for subtype 4, and the subpaths were miR‑34A/vinculin (VCL)/focal adhesion and miR‑34C/VCL/focal adhesion. In addition, Helicobacter pylori infection was higher in GC subtype 1 than in other subtypes. Specific genes, such as CACNA1E, CCL21, PSMD3 and VCL, may be used as potential feature genes to identify different subtypes of GC, and their associated subpaths may partially explain the pathogenetic mechanism of each GC subtype.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Nogueira A, Cabral M, Salles P, Araujo L, Rodrigues L, Rodrigues M, Oliveira C, Queiroz D, Rocha G and Oliveira A: Role of intestinal metaplasia and epithelial dysplasia in the pathogenesis of gastric carcinoma. Gastroenterology. 118:A14042000. View Article : Google Scholar

2 

Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI

3 

Massarrat S and Stolte M: Development of gastric cancer and its prevention. Arch Iran Med. 17:514–520. 2014.PubMed/NCBI

4 

Shah MA, Khanin R, Tang L, Janjigian YY, Klimstra DS, Gerdes H and Kelsen DP: Molecular classification of gastric cancer: A new paradigm. Clin Cancer Res. 17:2693–2701. 2011. View Article : Google Scholar : PubMed/NCBI

5 

De Aretxabala X, Yonemura Y, Sugiyama K, Hirose N, Kumaki T, Fushida S, Miwa K and Miyazaki I: Gastric cancer heterogeneity. Cancer. 63:791–798. 1989. View Article : Google Scholar : PubMed/NCBI

6 

Chang HR, Nam S, Kook MC, Kim KT, Liu X, Yao H, Jung HR, Lemos R Jr, Seo HH, Park HS, et al: HNF4α is a therapeutic target that links AMPK to WNT signalling in early-stage gastric cancer. Gut. 65:19–32. 2016. View Article : Google Scholar : PubMed/NCBI

7 

Jiao S, Wang H, Shi Z, Dong A, Zhang W, Song X, He F, Wang Y, Zhang Z, Wang W, et al: A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer. Cancer Cell. 25:166–180. 2014. View Article : Google Scholar : PubMed/NCBI

8 

Li Z, Yu X, Wang Y, Shen J, Wu WK, Liang J and Feng F: By downregulating TIAM1 expression, microRNA-329 suppresses gastric cancer invasion and growth. Oncotarget. 6:17559–17569. 2015.PubMed/NCBI

9 

Zhao X, Dou W, He L, Liang S, Tie J, Liu C, Li T, Lu Y, Mo P, Shi Y, et al: MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor. Oncogene. 32:1363–1372. 2013. View Article : Google Scholar : PubMed/NCBI

10 

Chen F, Zhuang M, Peng J, Wang X, Huang T, Li S, Lin M, Lin H, Xu Y, Li J, et al: Baicalein inhibits migration and invasion of gastric cancer cells through suppression of the TGF-β signaling pathway. Mol Med Rep. 10:1999–2003. 2014. View Article : Google Scholar : PubMed/NCBI

11 

Yanai K, Nagai S, Wada J, Yamanaka N, Nakamura M, Torata N, Noshiro H, Tsuneyoshi M, Tanaka M and Katano M: Hedgehog signaling pathway is a possible therapeutic target for gastric cancer. J Surg Oncol. 95:55–62. 2007. View Article : Google Scholar : PubMed/NCBI

12 

Cho JY, Lim JY, Cheong JH, Park YY, Yoon SL, Kim SM, Kim SB, Kim H, Hong SW, Park YN, et al: Gene expression signature-based prognostic risk score in gastric cancer. Clin Cancer Res. 17:1850–1857. 2011. View Article : Google Scholar : PubMed/NCBI

13 

Diaz-Romero J, Romeo S, Bovée JV, Hogendoorn PC, Heini PF and Mainil-Varlet P: Hierarchical clustering of flow cytometry data for the study of conventional central chondrosarcoma. J Cell Physiol. 225:601–611. 2010. View Article : Google Scholar : PubMed/NCBI

14 

De Ronde JJ, Rigaill G, Rottenberg S, Rodenhuis S and Wessels LF: Identifying subgroup markers in heterogeneous populations. Nucleic Acids Res. 41:e2002013. View Article : Google Scholar : PubMed/NCBI

15 

He L and Sarkar SK: On improving some adaptive BH procedures controlling the FDR under dependence. Electron J Stat. 7:2683–2701. 2013. View Article : Google Scholar

16 

Guttula SV, Allam A and Gumpeny RS: Analyzing microarray data of Alzheimer's using cluster analysis to identify the biomarker genes. Int J Alzheimers Dis. 2012:6494562012.PubMed/NCBI

17 

Di Pietro C, Di Pietro V, Emmanuele G, Ferro A, Maugeri T, Modica E, Pigola G, Pulvirenti A, Purrello M, Ragusa M, et al: AntiClustal: Multiple sequence alignment by antipole clustering and linear approximate 1-median computation. Proc IEEE Comput Soc Bioinform Conf. 2:pp. 326–336. 2003; PubMed/NCBI

18 

Su X, Song B, Wang X, Ma X, Xu J and Ning K: Meta-Mesh: Metagenomic data analysis system. Sheng Wu Gong Cheng Xue Bao. 30:6–17. 2014.(In Chinese). PubMed/NCBI

19 

Yu T and Peng H: Hierarchical clustering of high-throughput expression data based on general dependences. IEEE/ACM Trans Comput Biol Bioinform. 10:1080–1085. 2013. View Article : Google Scholar : PubMed/NCBI

20 

Liberzon A: A description of the molecular signatures database (MSigDB) web site. Methods Mol Biol. 1150:153–160. 2014. View Article : Google Scholar : PubMed/NCBI

21 

Li J and Lu Z: Pathway-based drug repositioning using causal inference. BMC Bioinformatics. 14 Suppl 16:S32013. View Article : Google Scholar : PubMed/NCBI

22 

Choi IK, Sung HJ, Lee JH, Kim JS and Seo JH: The relationship between Helicobacter pylori infection and the effects of chemotherapy in patients with advanced or metastatic gastric cancer. Cancer Chemother Pharmacol. 70:555–558. 2012. View Article : Google Scholar : PubMed/NCBI

23 

Wang K, Yuen ST, Xu J, Lee SP, Yan HH, Shi ST, Siu HC, Deng S, Chu KM, Law S, et al: Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. Nat Genet. 46:573–582. 2014. View Article : Google Scholar : PubMed/NCBI

24 

Uemura N, Okamoto S and Yamamoto S: H. pylori infection and the development of gastric cancer. Keio J Med. 51 Suppl 2:S63–S68. 2002. View Article : Google Scholar

25 

Tang ZZ, Liang MC, Lu S, Yu D, Yu CY, Yue DT and Soong TW: Transcript scanning reveals novel and extensive splice variations in human l-type voltage-gated calcium channel, Cav1.2 alpha1 subunit. J Biol Chem. 279:44335–44343. 2004. View Article : Google Scholar : PubMed/NCBI

26 

Yu XJ, Yang MJ, Zhou B, Wang GZ, Huang YC, Wu LC, Cheng X, Wen ZS, Huang JY, Zhang YD, et al: Characterization of somatic mutations in air pollution-related lung cancer. EBioMedicine. 2:583–590. 2015. View Article : Google Scholar : PubMed/NCBI

27 

Moler E, Rowe M, Tse C, Xu X and Yu G: CACNA1E in cancer diagnosis detection and treatment. EP 2062591 A1. 2009.

28 

Zhao Y, Li C, Wang M, Su L, Qu Y, Li J, Yu B, Yan M, Yu Y, Liu B and Zhu Z: Decrease of miR-202-3p expression, a novel tumor suppressor, in gastric cancer. PLoS One. 8:e697562013. View Article : Google Scholar : PubMed/NCBI

29 

Holmkvist J, Tojjar D, Almgren P, Lyssenko V, Lindgren CM, Isomaa B, Tuomi T, Berglund G, Renström E and Groop L: Polymorphisms in the gene encoding the voltage-dependent Ca(2+) channel Ca (V)2.3 (CACNA1E) are associated with type 2 diabetes and impaired insulin secretion. Diabetologia. 50:2467–2475. 2007. View Article : Google Scholar : PubMed/NCBI

30 

Lindkvist B, Almquist M, Bjørge T, Stocks T, Borena W, Johansen D, Hallmans G, Engeland A, Nagel G, Jonsson H, et al: Prospective cohort study of metabolic risk factors and gastric adenocarcinoma risk in the metabolic syndrome and cancer project (Me-Can). Cancer Causes Control. 24:107–116. 2013. View Article : Google Scholar : PubMed/NCBI

31 

Luther SA, Bidgol A, Hargreaves DC, Schmidt A, Xu Y, Paniyadi J, Matloubian M and Cyster JG: Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J Immunol. 169:424–433. 2002. View Article : Google Scholar : PubMed/NCBI

32 

Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, Egan LJ, Kagnoff MF and Karin M: IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell. 118:285–296. 2004. View Article : Google Scholar : PubMed/NCBI

33 

Leibovich-Rivkin T, Lebel-Haziv Y, Lerrer S, Weitzenfeld P and Ben-Baruch A: The versatile world of inflammatory chemokines in cancer. Springer Neth. 1–175. 2014.

34 

Sha M, Ye J, Zhang LX, Luan ZY, Chen YB and Huang JX: Celastrol induces apoptosis of gastric cancer cells by miR-21 inhibiting PI3K/Akt-NF-κB signaling pathway. Pharmacology. 93:39–46. 2014. View Article : Google Scholar : PubMed/NCBI

35 

Xia JT, Chen LZ, Jian WH, Wang KB, Yang YZ, He WL, He YL, Chen D and Li W: MicroRNA-362 induces cell proliferation and apoptosis resistance in gastric cancer by activation of NF-κB signaling. J Transl Med. 12:332014. View Article : Google Scholar : PubMed/NCBI

36 

Sha M, Ye J, Zhang L, Luan Z and Chen Y: Celastrol induces apoptosis of gastric cancer cells by miR-146a inhibition of NF-κB activity. Cancer Cell Int. 13:502013. View Article : Google Scholar : PubMed/NCBI

37 

Peng Y, Liu YM, Li LC, Wang LL and Wu XL: MicroRNA-338 inhibits growth, invasion and metastasis of gastric cancer by targeting NRP1 expression. PLoS One. 9:e944222014. View Article : Google Scholar : PubMed/NCBI

38 

Pang Y, Ball GR, Rakha EA, Powe DG, Caldas C, Ellis IO and Green AR: O-37 SOX11 and PSMD3 expression in HER2 positive breast cancer. Eur J Cancer Suppl. 8:1–36. 2010. View Article : Google Scholar

39 

Qian J, Zou Y, Hoeksema M, Harris B, Chen H and Massion P: Identification of FXR1-associated protein complexes in lung cancer. Cancer Res. 76:28732016. View Article : Google Scholar

40 

Hou Z, Li X, Yu L, Qian X and Liu B: MicroRNA-146a is down-regulated in gastric cancer and regulates cell proliferation and apoptosis. Med Oncol. 29:886–892. 2012. View Article : Google Scholar : PubMed/NCBI

41 

Dong HK, Chan JY, Jin KR, Middeldorp JM, Woo JH and Chang MS: Epstein-Barr virus-encoded BARF1 downregulates SMAD4 and increases miR-146a in gastric carcinoma cells. Cancer Res. 75:27162015. View Article : Google Scholar : PubMed/NCBI

42 

Jin GH, Wei X, Yang S and Wang LB: Celecoxib exhibits an anti-gastric cancer effect by targeting focal adhesion and leukocyte transendothelial migration-associated genes. Oncol Lett. 12:2345–2350. 2016. View Article : Google Scholar : PubMed/NCBI

43 

Zhang CH and Geng JS: Expression of paxillin and vinculin in gastric carcinoma and precancerous lesion and their effects on prognosis of gastric carcinoma. Chin J Diagn Pathol. 14:377–380. 2007.

44 

Wang Y, Kuramitsu Y, Ueno T, Suzuki N, Yoshino S, Iizuka N, Zhang X, Akada J, Oka M and Nakamura K: Proteomic differential display identifies upregulated vinculin as a possible biomarker of pancreatic cancer. Oncol Rep. 28:1845–1850. 2012. View Article : Google Scholar : PubMed/NCBI

45 

Li T, Guo H, Song Y, Zhao X, Shi Y, Lu Y, Hu S, Nie Y, Fan D and Wu K: Loss of vinculin and membrane-bound β-catenin promotes metastasis and predicts poor prognosis in colorectal cancer. Mol Cancer. 13:2632014. View Article : Google Scholar : PubMed/NCBI

46 

Wang AM, Huang TT, Hsu KW, Huang KH, Fang WL, Yang MH, Lo SS, Chi CW, Lin JJ and Yeh TS: Yin Yang 1 is a target of miR-34 family and contributes to gastric carcinogenesis. Oncotarget. 5:5002–5016. 2014. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Li Y, Bai W and Zhang X: Identifying heterogeneous subtypes of gastric cancer and subtype‑specific subpaths of microRNA‑target pathways. Mol Med Rep 17: 3583-3590, 2018.
APA
Li, Y., Bai, W., & Zhang, X. (2018). Identifying heterogeneous subtypes of gastric cancer and subtype‑specific subpaths of microRNA‑target pathways. Molecular Medicine Reports, 17, 3583-3590. https://doi.org/10.3892/mmr.2017.8329
MLA
Li, Y., Bai, W., Zhang, X."Identifying heterogeneous subtypes of gastric cancer and subtype‑specific subpaths of microRNA‑target pathways". Molecular Medicine Reports 17.3 (2018): 3583-3590.
Chicago
Li, Y., Bai, W., Zhang, X."Identifying heterogeneous subtypes of gastric cancer and subtype‑specific subpaths of microRNA‑target pathways". Molecular Medicine Reports 17, no. 3 (2018): 3583-3590. https://doi.org/10.3892/mmr.2017.8329
Copy and paste a formatted citation
x
Spandidos Publications style
Li Y, Bai W and Zhang X: Identifying heterogeneous subtypes of gastric cancer and subtype‑specific subpaths of microRNA‑target pathways. Mol Med Rep 17: 3583-3590, 2018.
APA
Li, Y., Bai, W., & Zhang, X. (2018). Identifying heterogeneous subtypes of gastric cancer and subtype‑specific subpaths of microRNA‑target pathways. Molecular Medicine Reports, 17, 3583-3590. https://doi.org/10.3892/mmr.2017.8329
MLA
Li, Y., Bai, W., Zhang, X."Identifying heterogeneous subtypes of gastric cancer and subtype‑specific subpaths of microRNA‑target pathways". Molecular Medicine Reports 17.3 (2018): 3583-3590.
Chicago
Li, Y., Bai, W., Zhang, X."Identifying heterogeneous subtypes of gastric cancer and subtype‑specific subpaths of microRNA‑target pathways". Molecular Medicine Reports 17, no. 3 (2018): 3583-3590. https://doi.org/10.3892/mmr.2017.8329
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team